FDA Brief

Warning letters Drugs

FDA warning letter to

Asesores en Mantenimiento Hidraulico e Industrial, S.A. de C.V.

High riskIssued Feb 22, 2021Posted Mar 2, 2021Center for Drug Evaluation and Research | CDER

Mexican drug manufacturer's hand sanitizer labeled 70% ethanol was found on border testing to contain mostly methanol instead.

What happened

FDA tested a batch of ARGENT Defense Group HAND SANITIZER that had been stopped at the U.S. border and refused admission; the product is labeled as made at this firm's Monterrey facility. The lab found an average of 0.07% ethanol and about 66% methanol, though the label declared 70% ethanol. FDA held a call with the firm and its U.S. agent on August 31, 2020, and placed all the firm's drugs on Import Alert 66-78 on September 2, 2020; the firm said no commercial product was in U.S. distribution and took no market action.

What FDA found

  1. The declared active ingredient, ethanol, was replaced in whole or in part with methanol, a dangerous chemical on skin or if swallowed.

    Section 501(d)(2) of the FD&C Act, 21 U.S.C. 351(d)(2)
  2. That substitution shows the firm's quality assurance is not working as required by current good manufacturing practice (CGMP), the basic manufacturing quality rules for drugs.

    Section 501(a)(2)(B) of the FD&C Act, 21 U.S.C. 351(a)(2)(B)
  3. The hand sanitizer is a new drug sold without FDA approval and does not meet the conditions for marketing without an application.

    Sections 505(a) and 301(d) of the FD&C Act, 21 U.S.C. 355(a) and 331(d)
  4. The product is dangerous to health when used as labeled because it contains methanol.

    Section 502(j) of the FD&C Act, 21 U.S.C. 352(j)
  5. The label says 70% ethanol but the product contains far less, so the labeling is false or misleading.

    Section 502(a) of the FD&C Act, 21 U.S.C. 352(a)
  6. The product is misbranded because it does not comply with the requirements for marketing nonprescription drugs under section 505G.

    Section 502(ee) of the FD&C Act, 21 U.S.C. 352(ee)

What FDA wants

Within 15 working days, respond in writing with an investigation into how the ethanol was replaced with methanol, a full list of raw materials and their suppliers, a list and reconciliation of all hand sanitizer batches shipped to the U.S., and complete batch records. FDA also strongly recommends hiring a qualified CGMP consultant before making drugs for the U.S. market again.

Who should pay attention

  • distributors and retailers selling ARGENT Defense Group branded hand sanitizer
  • importers and U.S. agents handling hand sanitizer from Mexican contract manufacturers
  • companies that source hand sanitizer from third-party or contract manufacturers

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. World Perfumes Inc.

    World Perfumes failed to test drug ingredients for toxic contaminants and had inadequate water, FDA says.

    High risk
  2. RNA Bio/Pharma, Incorporated

    FDA found RNA Bio/Pharma failed to test homeopathic oral liquid drugs for dangerous contaminants and did not validate its water system.

    High risk
  3. Kabana Skin Care LLC

    Kabana Skin Care failed to test OTC drug ingredients and finished products, prompting a recall and halt of U.S. drug manufacturing.

    High risk
  4. Ningbo Riway Industrial Co., Ltd.

    Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.

    High risk